| Financial Year |
March 31 2023 |
| Monetary Funds |
720,657,665.61 |
| Held-for-trading Financial Assets |
216,495,282.20 |
| Notes Receivable |
1,170,000.00 |
| Accounts Receivable |
337,390,745.81 |
| Advances to Suppliers |
12,430,000.05 |
| Other Receivables |
10,227,593.17 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
353,896,322.88 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
17,219,999.23 |
| Total Current Assets |
1,680,567,577.05 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
41,667,054.72 |
| Fixed Assetes |
602,953,055.81 |
| Under-construction Projects |
60,997,433.26 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
169,593,070.64 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
530,688.24 |
| Deferred Income Tax Assets |
42,082,713.85 |
| Other Non-Current Assets |
35,895,190.23 |
| Sub-Total of Non-Current Assets |
955,640,975.57 |
| Total Assets |
2,636,208,552.62 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
160,757,425.85 |
| Accounts Payable |
234,512,731.62 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
9,494,722.52 |
| Taxes Payable |
5,114,146.96 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
5,234,579.74 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,691,494.71 |
| Other Current Liabilities |
3,505,950.60 |
| Sub-Total of Current Liabilities |
452,470,012.42 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
35,839,255.85 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
83,336,529.56 |
| Total Liabilities |
535,806,541.98 |
| Paid-In Capital(Or Share Stock) |
125,993,700.00 |
| Capital Surplus |
1,217,921,642.00 |
| Surplus Reserve |
53,937,725.01 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
700,385,527.38 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,100,402,010.64 |
| Owner's Equity（Stockholder's Equity） |
2,100,402,010.64 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,636,208,552.62 |
